Stay updated with breaking news from New Biosimilar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
European Commission approves Celltrion Healthcare’s Vegzelma™ (CT-P16, biosimilar bevacizumab) for the treatment of multiple types of cancer · Vegzelma™ offers European patients living with certain types of breast, lung, renal, colon, rect...